|
|
| Countries covered: United States Maintaining Profitability in the Challenging Reimbursement Paradigm A major challenge in the dialysis industry is the high cost pressures faced by manufacturers and service providers. Medicare reimburses a majority of the treatments performed by dialysis clinics. The low Medicare reimbursement rates have put significant pressure on these clinics to reduce cost, which have forced manufacturers to contain profitability as well as threaten innovation. The imminent dearth in skilled staff for dialysis clinics and constraints of cost-containment within the current reimbursement system necessitate the development of novel methods to increase profitability. Solutions involve novel workflow cost containment strategies as well as consolidation of service providers and manufacturing companies, which allow increased margins. Growing Number of ESRD Patients will Drive Growth in the Dialysis Market The number of ESRD patients is expected to grow significantly, fueled by increases in the incidence of diabetes and obesity. Sheer growth in patient numbers will drive the market for dialysis products and services. Significant growth is expected in the market for dialyzers and in niche markets for machines such as the home hemodialysis market. Niche Markets like Home Hemodialysis Hold Untapped Potential Frequent or longer dialysis gives better clinical outcomes for patients than dialysis currently practiced in-center. Given the choice and means to do so, an estimated 50 percent of dialysis patients would chose to treat themselves at home. Medical Directors from several independent clinics are attempting to create home hemodialysis programs that both, benefit their patients and increase profits. Home hemodialysis is a solid value proposition for the future of the dialysis industry. It holds tremendous potential that has remained virtually untapped to date. Home hemodialysis significantly reduces the need to hire and train more staff to keep up with the growing patient population. These savings in cost per treatment make it possible to treat at home within the current reimbursement paradigm while increasing profit margins on treating patients who are beneficiaries of Medicare. New machines with better safety features and easier to use interfaces will increase confidence in patients’ ability to administer their own care. Machines that reduce the need for infrastructural changes at home. |
More United States Blood Reports
Therapeutic Apheresis by
Global Industry Analysts
This report analyzes the US market for Therapeutic Apheresis in US$ Thousand by the following procedures: Photopheresis, Plasmapheresis, Erythrocytapheresis, Plateletpheresis, Leukapheresis, and Lipidpheresis. The ...
Therapeutic Apheresis - A US Market Review by
BizAcumen, Inc.
Although therapeutic apheresis is a potential market, soaring treatment costs and lack of awareness debilitate its growth. However, with increasing alliances and agreements, research for ...
Medical Membrane Devices: Markets and Technologies by
BCC Research
This Report:
Provides a U.S. market review for medical membrane devices and technologies
Offers the current U.S. market status for medical membrane devices ...
US Markets for Clot Management Devices 2009 by
Millennium Research Group
The clot management device market will be predominantly driven by product innovations that result in more efficient treatment times, reduced complications, and better patient outcomes ...
Diagnostics and Therapeutics for Genetic Diseases by
BCC Research
REPORT HIGHLIGHTS
The U.S. market for therapeutics and diagnostics for genetic diseases reached $4.8 billion in 2005 and is expected to grow at an ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
